PremiumRatingsTeladoc’s Growth Potential Bolstered by Strategic Acquisition and Strong Performance Teladoc Health: Hold Rating Amid Strategic Acquisition and Segment Uncertainties Teladoc’s Strategic Moves and Financial Outlook: Hold Rating Amid Growth Potential and Margin Pressures PremiumThe FlyTeladoc sees Q2 EPS (40c)-(20c), consensus (26c) Teladoc acquires UpLift Health for $30M in cash Teladoc options imply 11.6% move in share price post-earnings PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, April 29 – May 02, 2025 Teladoc Inc. (TDOC) Q1 Earnings Cheat Sheet Most Anticipated Earnings this Week – Week of April 28, 2025 
